Janssen Biotech, Inc.

H Mimi Zhou

Ellen Chi

Wilson Edwards

Ann Lacombe

Matt Husovsky

Christian Martinez

Paul H Kim

Qiang Chen

Zemeda Ainekulu

Quynh Nguyen

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a KL2B413 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413.

Anti-idiotypic antibodies against anti-KLK2 antibodies

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.

Anti-idiotypic antibodies against anti-GPRC5D antibodies

Growing community of inventors

San Diego, CA, United States of America

H Mimi Zhou